By Jacob Engels
Brigham Buhler’s face has been popping up all over MAGA media lately – on Joe Rogan’s podcast, on Tucker Carlson’s show, even on InfoWars with Alex Jones – always introduced as a brave whistleblower exposing Big Pharma. He’s sidled up to our heroes like Robert F. Kennedy Jr. and Sen. Ron Johnson, branding himself as an “advisor” in the health freedom movement. On the surface, Buhler speaks our language: He rails against the FDA as corrupt, blasts Big Pharma greed, and talks about “health freedom” and alternative cures. But patriots, beware – behind the righteous rhetoric, Buhler is the head of a rogue medical enterprise that has been documented as illegally producing medications enriching himself while putting patient safety at risk nationwide.
Guys like Buhler threaten to embarrass and undermine the MAHA movement.
Buhler is the founder of a Houston drug compounding outfit called Revive RX Pharmacy and a telehealth clinic Ways2Well (his “wellness” venture launched in 2018). He loves to tell audiences he’s a former pharma rep who saw the light and is now fighting the “medical establishment.” On a June 27, 2023 episode of The Joe Rogan Experience, Buhler claimed the FDA is riddled with conflicts of interest, saying “A majority of the FDA’s funding comes from private industry… And they are being influenced by these companies”. He and Rogan suggested the FDA conspires with Big Pharma to crack down on small pharmacies: “Putting something on the dangerous list with no evidence seems like straight-cut corruption,” Rogan remarked in agreement. Buhler insisted that peptides and other alternative therapies are being suppressed just so Big Pharma can patent them – “all clues lead to FDA helping Big Pharma to patent certain peptides and compounds by classifying them as dangerous”. In other words, Buhler casts himself as the underdog pharmacist hero, defying a captured, evil FDA.
Buhler’s rallying cry of fighting healthcare corruption deeply resonates in the MAGA circles. He got invites onto the Tucker Carlson show, did a roundtable discussion with RFK Jr. about America’s healthcare system and was even billed as a “medical industry expert” featured on shows with figures such as Alex Jones and Dr. Jordan Peterson.
The insinuation is clear: he’s trying to wrap himself in the legitimacy of our movement’s icons to boost his own credibility and ultimately enrich himself.
But here’s what Buhler doesn’t advertise to the MAGA faithful: His pharmacy Revive RX has been documented as repeatedly violating the law and putting patients at risk, drawing serious scrutiny from the very regulators he demonizes. While Buhler was on tour calling the FDA corrupt, FDA investigators were finding egregious safety failures inside his Revive RX facility. In a June 30, 2023 letter, the FDA detailed how an inspection of Revive RX found “insanitary conditions” in the pharmacy’s sterile drug production area. According to that FDA letter, Buhler’s employees were preparing supposedly sterile injectables in ways that could easily contaminate the drugs with filth. Inspectors watched an employee reach bare-handed over open vials of medicine while capping them, and another failed to sanitize their gloves after handling trash in the cleanroom.
The pharmacy was even using a non-pharmaceutical-grade filter to sterilize drug solutions and then not testing if the filter actually worked. Basic safety steps like smoke tests to ensure proper airflow in cleanrooms hadn’t been done. The FDA flat-out warned that Revive RX’s purportedly sterile products were adulterated under federal law – in plain terms, tainted by contamination risk. Unsurprisingly, Buhler didn’t bring up his facility’s sanitation failures or his sales of illegal biological drugs during his testimony in front of the U.S. Senate where he claimed the healthcare system is rigged.
Even more alarming, the FDA found Buhler’s pharmacy was making and selling unapproved biological drugs that the FDA outlawed compounders from producing on March 23, 2020. For example, Revive RX was illegally manufacturing human chorionic gonadotropin (HCG) – a hormone drug that the FDA explicitly told him is an “unapproved new drug” and a biological product requiring a licensed approval, none of which the company has. “You do not have any FDA-approved applications on file for human chorionic gonadotropin (HCG) that you manufacture,” the FDA wrote, flatly declaring the product unlawful. In other words, Buhler’s pharmacy could still be illicitly compounding and selling HCG – skirting federal law while posturing as a righteous outsider. While Buhler rallies against the FDA and Big Pharma as the culprits behind declining health in America, he is running operations that could put patients’ health at risk nationwide by selling illegal medications.
But there’s more.
Buhler’s company was also compounding other biological products like Thymosin Beta-4 (TB4) for injury repair, which regulators never approved for use. (Only after getting caught did Buhler’s team claim they “voluntarily discontinued” making TB4). The FDA’s letter underscored that Buhler pharmacy was selling illegal medications and manufacturing substances that by law require FDA approval and rigorous trials. By selling these drugs to the public without approval, Revive RX was flouting federal law and putting consumers at risk with compounds of dubious safety. In FDA-speak, this is called misbranding and selling an unapproved new drug, violations that put the public’s health and safety at risk. In short, Buhler’s operation sidesteps the rules that legitimate drug manufacturers and pharmacies have to follow. Buhler is displaying the same greed and disregard for patient health that he has made his brand claiming others are guilty of.
Buhler’s apologists might say, “So what? The FDA is nitpicking to protect Big Pharma’s turf.” But the dangers here are very real – and they manifested in a major fiasco last year that directly endangered patients. In April 2024, Revive RX had to initiate a nationwide Class I recall of one of its drugs because the company mislabeled an injectable medication, with potentially devastating consequences. Revive RX had been selling vials of what customers thought was Tirzepatide – a high-demand weight-loss and diabetes drug (the active ingredient in Eli Lilly’s Mounjaro and ZepBound).
It turned out those vials actually contained testosterone cypionate rather than Tirzepatide.
Yep, that’s right. Buhler’s pharmacy mixed up the labels on a hormone steroid and a diabetes medication – a mistake that is as dangerous as it is absurd. The FDA classified this as a Class I recall, the most dire category, reserved for situations where “there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death”.
Think about that: a diabetes patient expecting a lifesaving medication could have unknowingly injected testosterone instead, or someone seeking weight loss could have been dosed with a powerful hormone their body didn’t need.
Former FDA Commissioner Stephen Ostroff was appalled, saying “It’s a serious error to mislabel a pharmaceutical in this way and it suggests that they have lax processes and procedures in place”. Indeed, it was, Revive RX’s general counsel at the time – Matthew Ludwig, Esq., is being sued by Revive RX’s competitor for alleged theft of trade secrets, which is a whole other story online – alerted the FDA to the mix-up, and the recall covered 751 vials shipped across the country. This wasn’t a tiny slip-up in a backroom; it was a mass distribution of dangerously mislabeled drugs. The same pharmacy had also recalled batches of Tirzepatide in May 2023 for being “sub-potent” (too weak) – further proof that quality control was lacking at Buhler’s company.
Out of all these dirty production fiascos at Revive RX, one must ask, where are the pharmacists? Are there any trained professionals on site?
Enter Aaron Schneider, Buhler’s main crony, right hand man and the pharmacist in charge. Schneider is supposed to ensure Revive follows all state and federal regulatory laws, procedures and directives, but patient safety instead takes a back seat to profit. Need more proof of this profits first, patient safety second model being pioneered by Buhler and Schneider? Revive RX did a Class 1 recall of its illegally compounded biological drug HCG for “Non-sterility; bacterial contamination identified as Paenibacillus Lautus.” Yes, another Class 1 recall. Did this stop Buhler and Schneider? Of course not. In fact, they doubled down and continued to illegally produce and sell more HCG to unsuspecting patients.
Buhler’s response to these offenses has not been to humble himself or fix the problems, but to double down on defiance. Internally, Revive RX’s lawyer put out sterile corporate statements about “vetting quality systems” and “enhancing our organization”. But publicly, Buhler just kept denying the FDA’s legitimacy to police him. He portrays the FDA enforcement as a political hit job – the big bad government coming after a small freedom fighter. On Rogan’s show, even as news of the FDA’s actions against Revive RX was emerging, Buhler waved away the agency’s authority, implying FDA oversight doesn’t apply to him because his pharmacy operates under a special exemption (Section 503A for compounders). He insinuated that any claims his products are “unsafe” are lies drummed up to protect pharma monopolies. Buhler has shown no contrition for the grave safety violations at Revive RX; instead, he frames the FDA as an illegitimate, biased actor. In his media appearances he’s scoffed that “Peptides aren’t even a drug – they’re short amino acids” and suggested the FDA has “no evidence” to justify banning compounds like BPC-157 or TB4. To hear Buhler tell it, he’s doing nothing wrong at all – it’s the “corrupt” FDA and pharma companies, not him, that endanger patients. This is classic grifter behavior: when caught red-handed, claim to be a martyr and cry “persecution.”
Deny, deflect and counter accuse, Buhler style.
Meanwhile, pharmaceutical companies have taken notice of Buhler’s scheme – and they’re not buying his freedom-fighter act. In late 2023, Eli Lilly & Co. sued Revive RX for illegally compounding and selling knock-off versions of Lilly’s drug Tirzepatide (branded as Mounjaro/ZepBound). Lilly rightfully argued that Buhler was profiting off their patented medication without approval, under the guise of “compounding”. If Big Pharma is so bad, why is Buhler copying their drugs?
Logical questions aside, Revive RX fought the case by twisting legal technicalities, effectively saying Lilly had no right to sue because only the FDA can enforce drug laws. (Imagine the irony: Buhler claims the FDA is corrupt, but then hides behind FDA authority in court to dodge liability.) The lawsuit underscored that Buhler’s business model was to piggyback on big manufacturers’ innovations, siphoning off profit by selling copycat drugs outside the law. While a judge temporarily stayed Lilly’s case due to jurisdictional questions, the message was clear – Revive RX’s activities are viewed as potentially unlawful and dangerous in the eyes of mainstream medicine.
It’s painfully evident that Brigham Buhler has been exploiting our side’s distrust of federal health agencies for his own gain. He sprinkles just enough truth in his rap – yes, the FDA and Big Pharma do have a revolving door; yes, we’ve seen regulatory capture and suppression of some treatments – to earn our sympathy. But then he uses that goodwill to peddle his own illegal lab-concocted biological drugs, all while telling us it’s part of the revolution against Big Pharma.
Buhler has been playing a double game: to the public he’s the noble crusader on InfoWars and at MAGA events, but behind closed doors he’s selling illegal compound biological drugs and running an enterprise so sloppy that vials of hormones get mailed out under the wrong labels. If we in the MAGA and the health freedom movement embrace characters like this, we are handing our enemies the rope to hang us with. The left-wing media would love nothing more than to tie this man’s dangerous antics around the neck of the entire conservative health freedom cause. Imagine how quickly they’ll pounce if a diabetic patient dies, or is harmed, because they got a bad drug from a pharmacy run by a self-proclaimed MAGA supporter. It would discredit everything legitimate we stand for in exposing big-pharma corruption.
The facts are indisputable and sourced: Buhler’s Revive RX has shipped mislabeled drugs under Class I recall, operated in filthy conditions per FDA inspectors, and sells illegal biological compound drugs the FDA explicitly deems illegal. These are the actions of a profiteering charlatan, not a patriot. No amount of smooth talking on podcasts can erase that reality. We in the MAGA movement must have the courage to police our own ranks and call out grifters who endanger people while wrapping themselves in our flag. Brigham Buhler is counting on us being so blinded by our distrust of the FDA that we overlook his recklessness and deceit. We can’t let that happen. Health freedom should mean empowering patients with safe alternatives – not empowering crooks to sell illegal compound biological drugs under a fake banner of liberty.
It’s time for this grift to be fully exposed.
Patriots, do your homework on those who claim to fight for you. Don’t forget, even President Trump himself went after Big Pharma’s misdeeds, but he would never condone distributing illegal compound biological drugs to unsuspecting Americans. There is a world of difference between cutting red tape for innovation and ignoring basic drug safety and the rule of law. Brigham Buhler has crossed that line. If our movement embraces men like him, we not only risk the health of our fellow Americans, we risk our movement’s soul and credibility.
The next time you see Buhler or someone like him boasting about taking on the FDA, remember what’s lurking beneath the rhetoric. This is a grifter in patriot’s clothing, and it’s our duty to the truth – and to the American people we serve – to expose and reject such charlatans before they do more harm. Let’s stand for real health freedom, not Buhler’s brand of freedom-to-grift.
